Absci (ABSI) Receivables - Net (2020 - 2026)
Absci (ABSI) posted Receivables - Net of $100000.0 for Q1 2026, down 90.0% sequentially from $1.0 million in Q3 2025, and down 92.77% YoY from $1.4 million in Q1 2025.
Absci (ABSI) Receivables - Net (2020 - 2026) Analysis & Trends
Absci has reported Receivables - Net for 7 years, with the latest figure at $100000.0 in Q1 2026.
- Quarterly Receivables - Net fell 92.77% year-over-year to $100000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $100000.0 (down 92.77% YoY) and the FY2023 annual result came in at $2.2 million, up 41.23% from the prior year.
- Receivables - Net slipped to $100000.0 in Q1 2026 per ABSI's latest filing, from $1.0 million in the prior quarter.
- Over five years, Receivables - Net peaked at $3.2 million in Q2 2023 and troughed at $42000.0 in Q1 2024.
- A 5-year average of $947466.7 and a median of $800000.0 in 2023 frame the typical range for Receivables - Net.
- The sharpest annual moves came in 2024 and 2025: Receivables - Net tumbled 98.61% in 2024, then jumped 3195.24% in 2025.
- Over 5 years, Receivables - Net stood at $1.1 million in 2022, then soared by 99.0% to $2.2 million in 2023, then plunged by 31.48% to $1.5 million in 2024, then plunged by 33.33% to $1.0 million in 2025, then sank by 90.0% to $100000.0 in 2026.
- According to Business Quant data, Receivables - Net over the past three periods registered $100000.0, $1.0 million, and $700000.0 for Q1 2026, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Absci | 1.58 Bn | 1.37 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 300,000.00 |
| Jun 30, 2026 | 300,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Sep 30, 2025 | 1.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 700,000.00 |
| Jun 30, 2025 | 700,000.00 |
| Mar 31, 2025 | 1.38 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Sep 30, 2024 | 1.50 Mn |
| Sep 30, 2024 | 1.50 Mn |
| Jun 30, 2024 | 44,000.00 |
| Jun 30, 2024 | 44,000.00 |
| Mar 31, 2024 | 42,000.00 |
| Mar 31, 2024 | 42,000.00 |
| Dec 31, 2023 | 2.19 Mn |
| Dec 31, 2023 | 2.19 Mn |
| Sep 30, 2023 | 800,000.00 |
| Sep 30, 2023 | 800,000.00 |